Experimental Zika Virus Inoculation in a New World Monkey Model Reproduces Key Features of the Human Infection
Charles Y Chiu1,2,3, Claudia Sánchez-San Martín4,5, Jerome Bouquet4,5
1Department of Laboratory Medicine, University of California, San Francisco, CA, 94107, USA. charles.chiu@ucsf.edu.
Scientific Reports
|December 8, 2017
Summary
A new marmoset model for Zika virus (ZIKV) infection shows promise for studying human disease. This primate model mimics ZIKV illness, including viral persistence in saliva and semen, aiding vaccine and drug development.
Area of Science:
- Virology
- Primate Models
- Infectious Diseases
Background:
- Zika virus (ZIKV) poses significant public health risks, including fetal brain defects and neurological illness.
- An urgent need exists for a suitable animal model to study ZIKV transmission and pathogenesis.
- Current models lack comprehensive similarities to human ZIKV infection.
Purpose of the Study:
- To establish and characterize a marmoset model for Zika virus infection.
- To evaluate ZIKV transmission routes and host immune responses in non-human primates.
- To assess the utility of the marmoset model for preclinical testing of ZIKV countermeasures.
Main Methods:
- Experimental infection of male marmosets with a prototype ZIKV strain.
- Clinical monitoring and collection of various body fluids and tissues over a 3-month period.
- Re-challenge experiments with a contemporary ZIKV outbreak strain to assess protective immunity.
Main Results:
- Marmosets exhibited mild or asymptomatic ZIKV infection, mirroring human illness.
- ZIKV persisted longer in saliva and semen than in serum, indicating potential for oral and sexual transmission.
- Infectious ZIKV was detected in saliva, supporting oral transmission routes.
- Neutralizing antibodies and antiviral immune responses were generated.
- Re-challenge conferred protection and boosted immune responses.
Conclusions:
- The marmoset model closely resembles human ZIKV infection, including asymptomatic presentation and viral persistence in key body fluids.
- The model supports the potential for ZIKV transmission via the oral route.
- This primate model is valuable for evaluating the efficacy of ZIKV vaccines and therapeutics.


